Graham (GHM) Valuation Check After Record Revenue Backlog Strength And Softer Profitability Guidance
Graham GHM | 0.00 |
Why Graham’s latest earnings and guidance matter for investors
Graham (GHM) has drawn fresh attention after reporting record fourth quarter and full year 2026 revenue, along with new fiscal 2027 net sales guidance of US$285 million to US$295 million and commentary on profitability.
The mixed reaction to Graham’s record results and 2027 guidance has pulled the share price back recently, with a 7 day share price return of 7.52% decline and a 30 day share price return of 2.3% decline. However, the year to date share price return of 44.71% and 1 year total shareholder return of 109.37% suggest momentum has been strong over a longer stretch as investors reassess the balance between growth and profitability.
If you are weighing up Graham’s recent move and want to broaden your watchlist, it could be worth scanning 34 power grid technology and infrastructure stocks as another way to find potential opportunities in critical infrastructure and energy related plays.
Record revenue, a backlog of US$532.6 million and a year to date share price gain of 44.71% sit against softer profitability guidance and a US$112.75 price target. Is there still upside here, or is future growth already priced in?
Most Popular Narrative: 4.2% Undervalued
Graham’s last close at $96.06 sits below the most followed narrative fair value of $100.25, which is built around multi year earnings and margin assumptions.
Record backlog growth and strong book to bill ratio signal rising multi year demand, underpinned by sustained U.S. Navy defense programs and increasing global infrastructure investment, supporting future revenue visibility and stability.
Want to see what is baked into that outlook beyond the headline backlog story? The narrative focuses on compound revenue and earnings growth together with margin improvements over several years. This framework is used to evaluate how those elements may support a higher valuation than today’s share price. The full breakdown lays out the numbers and the logic behind them.
Result: Fair Value of $100.25 (UNDERVALUED)
However, this hinges on continued U.S. defense spending and execution on new nuclear and hydrogen projects, where slower orders or delays could quickly challenge that fair value story.
Another Angle on Valuation: Earnings Multiple Tension
Analyst narratives see Graham as about 4.2% undervalued versus a fair value of $100.25, but the current P/E of 89.8x tells a different story. It sits far above both the estimated fair ratio of 36.7x and the US Machinery industry on 27.1x, as well as a 44.1x peer average. That gap points to meaningful valuation risk if sentiment cools or growth expectations are revised.
To stress test those expectations even further, it is worth looking at how the current price stacks up against our earnings based fair ratio workup in more detail, and how that compares with similar companies, before deciding whether the premium feels justified or stretched. See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
If this mix of strength and valuation tension has you thinking, do not wait on others to decide for you. Instead, check the 2 key rewards
Looking for more investment ideas?
If you want to keep building your watchlist, do not stop at one stock. The right tools can help you spot opportunities you might otherwise miss.
- Zero in on quality at a discount by reviewing 47 high quality undervalued stocks that combine solid fundamentals with prices that may not fully reflect their strengths.
- Strengthen your income focus by scanning 9 dividend fortresses that aim to pair higher yields with more resilient payout histories.
- Prioritise resilience by checking 63 resilient stocks with low risk scores that carry lower risk scores and may help balance out the more volatile areas of your portfolio.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
